MOHS

MOHS acquires major pharma company

by with No Comment BusinessNews

In pursuit of its strategy of vertical integration of its flagship healthcare and wellness business, MOHS Analytics has acquired majority ownership of Remed Pharmaceuticals, Inc., a research and development-driven company founded in 2002 by pharmaceutical industry pillar Remedios A. Rivera.

MOHS

Standing from Left to Right: Dr. Kenji M. Asano Jr.(MOHS SVP & Group CFO), Remedios A. Rivera, (Remed Chairman and President), Michael B. Hortaleza(MOHS Chairman and CEO), Jocelyn M. Aberin(Remed VP-Operations)

Remed owns established brands covering products in four different pharmaceutical categories—Vitacare, Respicare, Pediacare, and Gastrocare with over 20 brands in its portfolio. These products are distributed through some 4,500 outlets in major national and regional drugstores and pharmacy chains.  Remed has grown toa  leadership position in some of the pharmaceutical categories it is present in, and it is poised to introduce 5 more brands in the coming months.

This acquisition follows MOHS’s purchase in early 2024 of a controlling stake in Zenfro Corporation, a distribution company with a strong and expanding network in the South Greater Manila Area handling top food, beverage, home, and personal care products.

The acquisitions are in line with MOHS’s 5-year roadmap to grow into one of the major fully integrated health and wellness companies in the Philippines.

MOHS got a jump start in business by being among the first to bring in affordable test kits and equipment at the start of the COVID-19 pandemic. With the decline of the COVID business, MOHS quickly pivoted to affordable point-of-care and home test kits for the early detection of diseases such as urinary tract infection, dengue, and malaria. From this platform of and experience with affordable healthcare products, MOHS has diversified into other areas of healthcare, including healthcare software and technologies, and point-of-care innovative systems.

MOHS

Signing from Left to Right: Dr. Kenji M. Asano, Jr.(MOHS SVP & Group CFO), Remedios A. Rivera, (Remed Chairman and President), Michael B. Hortaleza(MOHS Chairman and CEO)

“Vertical integration of our health care business allows MOHS to control costs better to make our products more affordable and our business more sustainable,” says Michael B. Hortaleza, MOHS’s Chairman and CEO. “Our acquisitions this year follow our strategy of engaging in businesses that add value to Philippine society, by making a wide range of affordable healthcare products accessible to Filipinos nationwide. This is in line with the Philippine Government’s thrust of Universal Health Care and emphasis on primary and preventative health care.”

MOHS

“Remed’s strategic partnership with MOHS will enable synergies as the strengths of both companies complement each other,” says Remedios A. Rivera, Remed Chairman and President. “Remed can tap MOHS’s distribution expertise in channels it is not currently accessing, while MOHS can tap Remed’s field marketing force to push its health and wellness products to medical professionals. Such a strong partnership will unlock significant local and global growth for Remed.”

“The entry of MOHS into pharmaceuticals through Remed creates synergies from a strategic and financial viewpoint. With our professional operations and automated systems, we can fully realize these synergies,” says MOHS SVP and Group CFO Dr. Kenji M. Asano, Jr.

For more information on Remed Pharmaceuticals, Inc.,  you can visit their website at  https://remedpharmaph.com/.

image

A robot machine that unites aesthetics, and technology in hair care is now in the PHL

by with No Comment BusinessTechnology

BMPlus January 1, 2024, 2 minute read

Now there’s a way to minimize the effects of hair loss and bald spots in men and women. Hair loss often translates to the loss of confidence, sometimes with devastating results. There are very few treatments that successfully bring hair back or reduce hair loss and the results are often temporary.

“Help is on the way for those who are experiencing bald spots and hair loss. At the forefront of technology, we are bringing Scatter to the Philippines as an innovative, affordable, simple, and safe solution to these issues,” assured Michael Hortaleza, CEO of MOHS Dermatology, the exclusive distributor of Scatter in the Philippines.“

Scatter, the groundbreaking way of minimizing the unsightly effects of bald spots and hair loss, was introduced at the 11th Annual Convention of the Philippine Academy of Aesthetics and Age Management Medicine Inc. (PAAAMI).

Eddy Kim, inventor and owner of Scatter and master Scatter from Korea, conducted a live demo and lecture, providing attendees with a firsthand look at this transformative technology. In his demonstration, Kim showed how the Scatter machine can be used here in the Philippines.  “Scatter is the blending of art and technology,” remarked Kim. 

The Scatter machine is an innovative Scalp Micropigmentation Technology from Korea that combines computer technology with the art and science of aesthetics.

Essentially, Scatter is programmed like a computer to tattoo hair-like spots on the scalp to darken bald spots and areas of thinning hair. The spots are precisely placed so that they simulate actual hair to give the illusion of a full head of hair.

Scatter treatment will be available at select dermatologists, who will receive the necessary training to use this game-changing technology.

MOHS Dermatology is the professional dermatology arm of MOHS Analytics, a fast-growing diversified company that prides itself on providing quality health and wellness solutions through technology that addresses what is needed by Filipinos nationwide.

inventory_backdrop

Companies shift focus as Covid-19 threat diminishes

by with No Comment BusinessNews

BY AARON RECUENCO

Mar 3, 2024 05:02 PM

As the threat of Covid-19 has already been significantly reduced in the country, some companies which earlier invested in point-of-care and home test kits, have started shifting its operations to other business lines.

In the case of the local company MOHS, it pivoted its business ventures to businesses include products and services in retail, dermatology and medical services, technology services, distribution and logistics.  

“We knew as early as 2022 that we needed to pivot to non-COVID products with the pandemic winding down. We aggressively moved into new lines, particularly health care and dermatology, as we know these businesses well, and sought the vertical integration of our operations through strategic acquisitions in distribution and logistics and technology services,” said MOHS chief executive officer Michael B. Hortaleza.

“These new businesses remain true to MOHS’s DNA of engaging in businesses that add value to Philippine society. Our COVID diagnostics and consumables business and home-based test kits certainly helped ease the physiological and financial burden that the pandemic brought to many patients,” he added.

While the COVID-19 business amounted for 100 percent of sales in 2021 and 2022, non-COVID sales accounted for 40 percent of MOHS business in 2023 and is projected to increase to 99 percent in 2024.

In 2023, even with COVID-19 cases rapidly declining, MOHS’s revenues grew by 24 percent. 

The group’s chief finance officer, Kenji M. Asano Jr., says, “MOHS’s timely pivot beyond its COVID-19 business, under the strategic direction of CEO Hortaleza, positions MOHS for rapid and sustained growth in 2024 and beyond. MOHS’s new product and services mix is poised to meet the exciting challenges of the post-pandemic era.”   

Diversifying into other business lines with established brands and aggressive competitors meant that the playing field was going to be tougher and in the case of the MOHS, some of its business ventures include dermatology clinics—the Arkana neurocosmetics and Swiss Image skin care products, and Scatter scalp micropigmentation technology for hair loss and bald spots.

Its recent acquisition of Zenfro Corporation, a distribution company in South GMA and modern trade distributing food, beverage and personal care products, expands MOHS’s distribution footprint and product lines.

Likewise, its purchase of Revery Digital Technologies brings it in-house technology services as well as new services in digital transformation and Artificial Intelligence to small and medium-sized enterprises.

Zenfro, Zenfro Corporation, Mike Hortaleza, MOHS

MOHS completes acquisition of distribution company

by with No Comment Business

February 13, 2024

MOHS Analytics, a company rapidly pivoting from the COVID-19 business that jumpstarted its growth and market presence, is diversifying into distribution.

In January, it completed the acquisition of Zenfro Corporation, a company that has a significant presence in the South Greater Manila Area (GMA) distributing food, beverage, and personal care products.

The acquisition expands the distribution footprint of MOHS Analytics. From its initial products in laboratory and home-based test kits for COVID-19 and other diseases, MOHS has diversified into other health and personal care products, like Arkana neurosciences, Swiss Image lines of skin care products, and is now into food and fast-moving consumer goods.

With MOHS as its owner, Zenfro is planning to expand to the whole Philippines. Zenfro now also has the muscle to engage new principals and is on track to signing new principals that will continue to add to the wide range of products it distributes.

Alongside the expansion are the improvements being done in operations as Zenfro is now in the process of implementing a new warehouse management system to cater to its increased distribution operations.

“Our acquisition of Zenfro unlocks synergies for both MOHS and Zenfro. Zenfro provides MOHS with a proven distribution channel for its rapidly expanding range of health and personal care products. MOHS provides Zenfro with financial resources and a broader range of products to distribute. These synergies provide strategic advantages that will be realized now and in the future,” MOHS Chairman and CEO Michael Hortaleza said.

“We welcome the acquisition of Zenfro by MOHS as together our joint operations will become more efficient. MOHS’ large distribution warehouse in Parañaque opens new possibilities for more efficient logistics and warehousing for Zenfro,” Zenfro Operations Manager and Director Clifton Ivor Poole said.

Moreover, Zenfro, by leveraging the know-how and expertise of MOHS in product innovation, will undertake the development of in-house brands for distribution.

https://www.manilatimes.net/2024/02/13/public-square/mohs-completes-acquisition-of-distribution-company/1932232?fbclid=IwAR29gw1adzOdomk0LdFJD27i0ryjAFw6oIetkS2nndIPcGXqRJA87ejxRbk

Mike Hortaleza, Arkana, Neuroscience in Skincare, Neurocosmetics

Introducing Neuroscience in Skincare: Arkana by MOHS Dermatology

by with No Comment BusinessTechnology

By Manila Standard Business

MOHS Dermatology, the fast-growing professional dermatology arm of MOHS Analytics, has introduced Arkana Neurocosmetics into the Philippine market. The introduction of high-quality neuro-cosmetics skincare products marks MOHS Dermatology’s dedication to the convergence of neuroscience and skincare.

A trusted European skincare brand, Arkana is at the forefront of the emerging field of neurocosmetics This discipline focuses on understanding the brain-skin connection to develop products that optimally enhance skin health. By incorporating neuroscientific principles into skincare, Arkana’s neuro-cosmetics range promises a deeper level of skin nourishment and rejuvenation.

“Neurocosmetics, which fuses science and beauty, set Arkana apart from other derma products,” says Evelyn Santiago, MOHS marketing manager. “Arkana’s potent line of skin care products uses the body’s neurotransmitters to signal how the body should repair and enhance the skin, ensuring greater safety and effectiveness.”

Arkana’s dedication to neurocosmetics underlines a commitment to progressive skincare solutions deeply rooted in scientific research and innovation. By integrating the latest advancements in neuroscience into skincare, Arkana offers skincare products that are not only effective but also at the cutting edge of scientific understanding.

about:blank

Arkana’s extensive range of products is meticulously crafted in Europe to cater to a myriad of skin types, spanning all ages and addressing various skin concerns. With over 200 scientifically developed products, each built upon more than 80 original cosmetic formulas, Arkana has developed a collection of products that guarantees a perfect match for every individual.

Arkana understands that each skin is different and needs a unique treatment regimen. Available only through dermatologists, Arkana’s wide-ranging product selection is designed to seamlessly align with diverse preferences and requirements. Whether a person is navigating the nuances of aging, grappling with specific skin issues, or seeking products tailored to their skin type, dermatologists will help their patients find a suitable Arkana product that will meet or exceed their expectations. Committed to neurocosmetics, Arkana is redefining the boundaries of effective skincare, making its users achieve the beautiful skin they deserve.

Arkana is exclusively imported by MOHS Dermatology, the professional dermatology arm of MOHS Analytics, a fast-growing diversified company that prides itself on providing quality health and wellness solutions through technology that addresses what is needed by Filipinos nationwide.

Introducing Neuroscience in Skincare: Arkana by MOHS Dermatology